Tiletamine And Zolazepam

14 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

2860.0%

Death Rate

Active Ingredients

Tiletamine And Zolazepam

Administration Routes

UnknownIntramuscularIntravenous

Species Affected

Dog 8

Cat 6

Most Affected Breeds

Domestic Shorthair 4

Dog (unknown) 2

Lhasa Apso 1

Chihuahua 1

Shih Tzu 1

Terrier (unspecified) 1

Retriever - Labrador 1

Cat (other) 1

Shiba Inu 1

Maine Coon 1

Most Reported Reactions

Death 3

Vomiting 2

Palpebral disorder NOS 2

Wound 2

Injection site necrosis 2

Bradycardia 2

Unresponsive to stimuli 2

Underdose 2

Facial swelling (see also 'Skin') 1

Anaphylactoid reaction 1

Ear discharge 1

Impaired hearing 1

Outcome Breakdown

Outcome Unknown

5 (35.7%)

Recovered/Normal

4 (28.6%)

Died

3 (21.4%)

Euthanized

1 (7.1%)

Ongoing

1 (7.1%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.